Feretis Themistoklis, Katselis Charalampos, Papanikolaou Ioannis G, Apostolou Konstantinos, Tsikalakis Spyridon, Toutouzas Konstantinos G, Theodoropoulos George, Trigka Eleni Andrianna, Saetta Angelica A, Alexakis Nicholas, Konstandoulakis Manousos, Tsarea Kalliopi, Karamperi Maria, Kletsas Dimitrios, Patsouris Efstratios, Manouras Andreas, Zografos Georgios C, Papalois Apostolos
1st Department of Propaedeutic Surgery, Medical School, National Kapodistrian University of Athens, Hippocratio Hospital Athens 11527, Greece.
Experimental, Educational Research Center, ELPEN Pharmaceuticals 190 09 Pikermi, Greece.
Am J Stem Cells. 2020 Jun 15;9(3):36-56. eCollection 2020.
Drug-induced liver injury (DILI) is a leading cause of acute liver injury (ALI). Acetaminophen (also termed paracetamol), can often be found in drugs that may be abused (i.e., prescription for pain relief). Animal experiments have shown that mesenchymal stem cell transplantation can ameliorate or even reverse hepatic injury.
ALI was induced in Wistar rats using paracetamol. ATSCs were transplanted via the intravenous, portal vein, or intrahepatic route directly onto the liver parenchyma. Histological evaluation was conducted to assess drug-induced injury following transplantation. Fluorescence in situ hybridization (FISH) was used to verify the location of stem cells on the liver parenchyma. The effect of those cells on liver regeneration was tested by immunohistochemistry for hepatic growth factor (HGF). In addition, reverse transcription-quantitative PCR (qRT-PCR) was used to assess hepatic growth factor (HGF), hepatic nuclear factor 4α (HNF4α), cytochrome P450 1A2 (CYP1A2) and α-fetoprotein (AFP) mRNA expression.
Immunohistochemical staining for HGF was stronger in the transplanted groups than that in the control group (P<0.001). HNF4α and HGF mRNA levels were increased on day 7 following transplantation (P<0.001 and P=0.009, respectively). CYP1A2 mRNA levels were also increased (P=0.013) in the intravenous groups, while AFP levels were higher in the intrahepatic groups (P=0.006). ATSC transplantation attenuates ALI injury and promotes liver regeneration. Furthermore, expression of specific hepatic enzymes points to ATSC hepatic differentiation.
The study showed the positive effects of transplanted adipose tissue stem cells (ATSCs) on liver regeneration (LG) through hepatotrophic factors. Furthermore, increased expression of hepatic specific proteins was recorded in ATSC transplanted groups that indicate stem cells differentiation into hepatic cells.
药物性肝损伤(DILI)是急性肝损伤(ALI)的主要原因。对乙酰氨基酚(也称为扑热息痛)常在可能被滥用的药物中出现(即用于止痛的处方药)。动物实验表明,间充质干细胞移植可改善甚至逆转肝损伤。
用对乙酰氨基酚诱导Wistar大鼠发生ALI。通过静脉、门静脉或肝内途径将脂肪干细胞(ATSCs)直接移植到肝实质。进行组织学评估以评估移植后药物诱导的损伤。采用荧光原位杂交(FISH)验证干细胞在肝实质的位置。通过免疫组织化学检测肝生长因子(HGF)来测试这些细胞对肝再生的作用。此外,采用逆转录定量PCR(qRT-PCR)评估肝生长因子(HGF)、肝细胞核因子4α(HNF4α)、细胞色素P450 1A2(CYP1A2)和甲胎蛋白(AFP)的mRNA表达。
移植组HGF免疫组织化学染色强于对照组(P<0.001)。移植后第7天HNF4α和HGF mRNA水平升高(分别为P<0.001和P=0.009)。静脉注射组CYP1A2 mRNA水平也升高(P=0.013),而肝内注射组AFP水平更高(P=0.006)。ATSC移植减轻ALI损伤并促进肝再生。此外,特定肝酶的表达表明ATSC向肝分化。
该研究显示了移植脂肪组织干细胞(ATSCs)通过肝营养因子对肝再生(LG)的积极作用。此外,在ATSC移植组中记录到肝特异性蛋白表达增加,表明干细胞分化为肝细胞。